Dormakaba sees organic net sales growth of 3-5% in FY25/26

Dormakaba sees organic net sales growth of 3-5% in FY25/26

Dormakaba Holding AG has announced that it expects organic net sales growth of 3-5% for the financial year 2025/26. This projection follows the company's strong performance in the previous financial year, where it reported a 4.1% organic net sales growth [1].

The company's CEO, Till Reuter, commented on the expected growth, stating, "Our team delivered a strong performance for 2024/25, which keeps us well on track for achieving our mid-term targets. The year was characterized by consequent strategy execution which resulted in good organic growth and continued margin expansion" [1].

Dormakaba's strong performance in 2024/25 was driven by a combination of volume growth and pricing increases, with organic net sales growth of 4.1% [1]. The company also saw an increase in its adjusted EBITDA margin to 15.5% [1].

Looking ahead to 2025/26, Dormakaba expects a robust trading environment despite global uncertainties. Lower interest rates in Europe, regulatory changes, infrastructure packages in Germany, and increased investment activities in the USA are expected to underpin opportunities for growth [1].

In addition to organic sales growth, Dormakaba aims to maintain an adjusted EBITDA margin above 16% and an adjusted operating cash flow margin of 11.5-12.5% for the financial year 2025/26 [1].

References:
[1] https://www.tradingview.com/news/eqs:fbf7aa64c094b:0-financial-year-2024-25-strong-performance-on-track-to-deliver-mid-term-targets/